Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Kansas City, Missouri 64111


The purpose of this study is to determine the efficacy of intravenous Exenatide therapy in hyperglycemic patients admitted to the coronary intensive care unit.

Study summary:

Diabetic patients with acute myocardial infarction (MI) have particularly poor outcomes. Clinical practice guidelines from the American College of Cardiology/American Heart Association for the treatment of patients with acute coronary syndromes call for treatment to achieve preprandial glucose <110 mg/dL, a maximum daily target <180 mg/dL, and a post-discharge hemoglobin A1c <7%. Initiation of aggressive insulin therapy is also warranted to achieve blood glucose <150 mg/dL during days 0-3 and 80-110 mg/dL when possible thereafter. To date, no studies have been conducted assessing the efficacy of intravenous exenatide administration on achieving glucose lowering in hyperglycemic coronary ICU patients.


Inclusion Criteria: - Admission to coronary ICU - Admission blood glucose 140-299 mg/dL - Primary cardiovascular diagnosis by attending physician - Under primary care of cardiology service - Age > 18 years old - Ventilator independent - Able to provide informed consent Exclusion Criteria: - Admission blood glucose < 140 or > 300 mg/dL - Ventilator dependent - Unconscious sedation - Type 1 diabetes - Known pregnancy - Admitted to coronary ICU for right heart cath to measure hemodynamics prior to transplant - Post transplant procedure - Currently enrolled in another clinical trial - Unable to provide informed consent - Creatinine clearance < 30 mL/min - On insulin treatment except for monotherapy with long-acting basal insulin (e.g., insulin glargine [Lantus®] or detemir [Levemir®]) - Gastroparesis



Primary Contact:

Principal Investigator
Steven P Marso, MD
Mid America Heart Institute Saint Luke's Health System

Backup Contact:


Location Contact:

Kansas City, Missouri 64111
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.